Our study revealed that a nontranscriptional mechanism of FXR that FXR forms a complex with β-catenin and subsequently disturbs the transcriptional activity of the β-catenin/TCF complex in colon cancer lines (theme II). The gene discussed is NR1H4; the disease is malignant colon neoplasm.